4//SEC Filing
Shemesh Shay 4
Accession 0001104659-24-060261
CIK 0001875558other
Filed
May 12, 8:00 PM ET
Accepted
May 13, 8:47 AM ET
Size
5.4 KB
Accession
0001104659-24-060261
Insider Transaction Report
Form 4
Shemesh Shay
Chief Dev. & Ops. Officer
Transactions
- Purchase
Common Stock
2024-05-10$6.32/sh+1,113$7,034→ 1,493,068 total
Footnotes (2)
- [F1]Reflects the weighted average purchase price. The range of prices for the shares purchased was $6.19 to $6.42. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price
- [F2]Includes 353,399 shares of restricted stock.
Documents
Issuer
Nuvectis Pharma, Inc.
CIK 0001875558
Entity typeother
Related Parties
1- filerCIK 0001896056
Filing Metadata
- Form type
- 4
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 8:47 AM ET
- Size
- 5.4 KB